Anna Lübking
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 10
- Chronic Myeloid Leukemia Treatments 9
- Genetics 9
- Chronic Lymphocytic Leukemia Research 7
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Shabnam Kharazi (2 shared papers)Christina T. Jensen (2 shared papers)Sten Eirik W. Jacobsen (2 shared papers)Charlotta Böiers (2 shared papers)Ewa Sitnicka (2 shared papers)Johan Richter (7 shared papers)Ulla Olsson‐Strömberg (6 shared papers)Leif Stenke (7 shared papers)
In The Last Decade
Anna Lübking
14 papers receiving 233 citations
Peers
Comparison fields: 5 of 30
- Hematology 156
- Genetics 109
- Rheumatology 66
- Immunology 65
- Oncology 55
Countries citing papers authored by Anna Lübking
This map shows the geographic impact of Anna Lübking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lübking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lübking more than expected).
Fields of papers citing papers by Anna Lübking
This network shows the impact of papers produced by Anna Lübking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lübking. The network helps show where Anna Lübking may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Lübking, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 49 | |
| 2 | 2008 | 43 | |
| 3 | 2019 | 25 | |
| 4 | 2019 | 23 | |
| 5 | 2015 | 18 | |
| 6 | 2021 | 16 | |
| 7 | 2007 | 13 | |
| 8 | 2015 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2015 | 8 | |
| 11 | 2016 | 7 | |
| 12 | 2020 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2004 | 1 |
About Anna Lübking
Anna Lübking is a scholar working on Hematology, Genetics, Rheumatology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 236 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Eosinophilic Disorders and Syndromes (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). The work is most often cited by research in Hematology (156 citations), Genetics (109 citations), Rheumatology (66 citations), Immunology (65 citations) and Oncology (55 citations). Anna Lübking has collaborated with scholars based in Sweden, Norway and Finland. Frequent co-authors include Shabnam Kharazi, Christina T. Jensen, Sten Eirik W. Jacobsen, Charlotta Böiers, Ewa Sitnicka, Johan Richter, Ulla Olsson‐Strömberg, Leif Stenke, Martin Höglund and Berit Markevärn. Their work appears in journals such as Blood, European Journal Of Haematology, Leukemia, British Journal of Haematology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.